JP2010532657A5 - - Google Patents

Download PDF

Info

Publication number
JP2010532657A5
JP2010532657A5 JP2010504730A JP2010504730A JP2010532657A5 JP 2010532657 A5 JP2010532657 A5 JP 2010532657A5 JP 2010504730 A JP2010504730 A JP 2010504730A JP 2010504730 A JP2010504730 A JP 2010504730A JP 2010532657 A5 JP2010532657 A5 JP 2010532657A5
Authority
JP
Japan
Prior art keywords
nucleic acid
antigen
acid molecule
fragment
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010504730A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010532657A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2008/055214 external-priority patent/WO2008135446A2/en
Publication of JP2010532657A publication Critical patent/JP2010532657A/ja
Publication of JP2010532657A5 publication Critical patent/JP2010532657A5/ja
Pending legal-status Critical Current

Links

JP2010504730A 2007-05-02 2008-04-29 クレブシエラ属の抗原 Pending JP2010532657A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07107344 2007-05-02
PCT/EP2008/055214 WO2008135446A2 (en) 2007-05-02 2008-04-29 Klebsiella antigens

Publications (2)

Publication Number Publication Date
JP2010532657A JP2010532657A (ja) 2010-10-14
JP2010532657A5 true JP2010532657A5 (OSRAM) 2011-07-14

Family

ID=39708006

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010504730A Pending JP2010532657A (ja) 2007-05-02 2008-04-29 クレブシエラ属の抗原

Country Status (7)

Country Link
US (3) US8236326B2 (OSRAM)
EP (5) EP2152731A2 (OSRAM)
JP (1) JP2010532657A (OSRAM)
CN (1) CN102015754A (OSRAM)
AU (1) AU2008248755A1 (OSRAM)
CA (1) CA2685805A1 (OSRAM)
WO (1) WO2008135446A2 (OSRAM)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2152731A2 (en) * 2007-05-02 2010-02-17 Intercell AG Klebsiella antigens
AU2009287339B2 (en) * 2008-08-28 2015-11-26 The University Of Queensland Mutant bacterial glycoproteins and uses thereof
WO2013112696A1 (en) * 2012-01-27 2013-08-01 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Compositions and methods for immunization against bacteria expressing a carbapenemase
KR101605846B1 (ko) * 2013-11-20 2016-03-23 한국과학기술연구원 클렙시엘라 뉴모니아에 특이적으로 결합하는 단일가닥 핵산 앱타머 및 이를 이용한 클렙시엘라 뉴모니아 검출 방법
EP4279080A3 (en) * 2015-01-12 2024-02-21 Evaxion Biotech A/S Treatment and prophylaxis of k. pneumoniae infection
CA2991907A1 (en) * 2015-07-10 2017-01-19 Douglas T. Burkhardt Proteins and immunizing compositions containing klebsiella proteins and methods of use
MX2018001964A (es) * 2015-08-24 2018-06-19 Medimmune Llc Polipeptidos mrka, anticuerpos y usos de los mismos.
MX2018005015A (es) * 2015-10-28 2019-06-24 Arsanis Biosciences Gmbh Anticuerpos dirigidos a un antigeno-o de manano de la k. pneumoniae.
SG11201900027XA (en) * 2016-08-05 2019-02-27 Medimmune Llc Anti-o2 antibodies and uses thereof
EP3497124A1 (en) 2016-08-12 2019-06-19 ARSANIS Biosciences GmbH Klebsiella pneumoniae o3 specific antibodies
WO2018075375A1 (en) * 2016-10-19 2018-04-26 Medimmune, Llc Anti-o1 antibodies and uses thereof
CN110540599B (zh) * 2018-12-20 2021-04-06 湖北工业大学 基于肺炎克雷伯菌表面蛋白抗体的肺炎克雷伯菌Elisa检测试剂盒及制备方法
CN110540600B (zh) * 2018-12-20 2021-01-29 湖北工业大学 基于肺炎克雷伯菌表面蛋白的乳胶微球免疫层析试纸的制备方法
CN110540595B (zh) * 2018-12-20 2021-04-06 湖北工业大学 一种肺炎克雷伯菌抗体乳胶微球免疫层析检测试纸的制备方法
CN111150839A (zh) * 2019-12-17 2020-05-15 中国科学院深圳先进技术研究院 一种用于免疫接种的组合物及其制备方法
CN112505324A (zh) * 2020-11-06 2021-03-16 杭州迅耀生物科技有限公司 一种新型冠状病毒检测方法
CN116033922B (zh) * 2021-08-25 2025-08-19 北京三诺佳邑生物技术有限责任公司 特异性识别肺炎克雷伯菌o1抗原的抗体及其应用
CN115838431A (zh) * 2022-07-08 2023-03-24 中国人民解放军陆军军医大学 一种用作肺炎克雷伯菌疫苗抗原的融合蛋白KP-Ag2及其应用

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8422238D0 (en) 1984-09-03 1984-10-10 Neuberger M S Chimeric proteins
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
US4946778A (en) * 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
IL162181A (en) 1988-12-28 2006-04-10 Pdl Biopharma Inc A method of producing humanized immunoglubulin, and polynucleotides encoding the same
WO1991018088A1 (en) 1990-05-23 1991-11-28 The United States Of America, Represented By The Secretary, United States Department Of Commerce Adeno-associated virus (aav)-based eucaryotic vectors
KR970002255B1 (ko) 1990-06-11 1997-02-26 넥스스타 파아마슈티컬드, 인크. 핵산 리간드
DK0464533T3 (da) 1990-06-28 1999-04-26 Gen Hospital Corp Fusionsproteiner med immunglobulindele, deres fremstilling og anvendelse
EP0772619B2 (en) 1994-07-15 2010-12-08 The University of Iowa Research Foundation Immunomodulatory oligonucleotides
RS50101B (sr) 1996-02-24 2009-01-22 Boehringer Ingelheim International Gmbh., Farmaceutski preparati za imunomodulaciju
JP2001504448A (ja) 1996-08-30 2001-04-03 フュルステ，イェンス，ペーター 核酸の鏡面対称選択および進化
US5849902A (en) 1996-09-26 1998-12-15 Oligos Etc. Inc. Three component chimeric antisense oligonucleotides
US6958239B2 (en) 1996-11-21 2005-10-25 Oligos Etc Inc. Three component chimeric antisense oligonucleotides
DE19742706B4 (de) 1997-09-26 2013-07-25 Pieris Proteolab Ag Lipocalinmuteine
DE19803453A1 (de) 1998-01-30 1999-08-12 Boehringer Ingelheim Int Vakzine
US6610836B1 (en) * 1999-01-29 2003-08-26 Genome Therapeutics Corporation Nucleic acid amino acid sequences relating to Klebsiella pneumoniae for diagnostics and therapeutics
AT408721B (de) 1999-10-01 2002-02-25 Cistem Biotechnologies Gmbh Pharmazeutische zusammensetzung enthaltend ein antigen
AT409085B (de) 2000-01-28 2002-05-27 Cistem Biotechnologies Gmbh Pharmazeutische zusammensetzung zur immunmodulation und herstellung von vakzinen
WO2001078767A2 (en) 2000-04-14 2001-10-25 Cistem Biotechnologies Gmbh Pharmaceutical preparations comprising modified peptides
AT410173B (de) 2000-06-08 2003-02-25 Cistem Biotechnologies Gmbh Antigene zusammensetzung
RU2413520C2 (ru) 2000-06-08 2011-03-10 Интерселл Аг Вакцинная композиция, содержащая иммуностимулирующие олигодезоксинуклеотиды
CA2418854A1 (en) 2000-08-17 2002-02-21 Jorg Fritz A vaccine which comprises at least one antigen and a cathelididin derived antimicrobial peptide or a derivative thereof
AT410635B (de) 2000-10-18 2003-06-25 Cistem Biotechnologies Gmbh Vakzin-zusammensetzung
EP1390495B1 (en) 2001-05-21 2007-07-04 Intercell AG Immunostimulatory oligodeoxynucleic molecules
WO2003047602A1 (en) 2001-12-07 2003-06-12 Intercell Ag Immunostimulatory oligodeoxynucleotides
WO2005103073A2 (en) * 2004-04-27 2005-11-03 Intercell Ag Td antigens
EP2152731A2 (en) * 2007-05-02 2010-02-17 Intercell AG Klebsiella antigens
DE102012005675A1 (de) 2012-03-21 2013-09-26 Daimler Ag Kraftfahrzeugantriebsstrangvorrichtung mit einem Mehrgruppengetriebe

Similar Documents

Publication Publication Date Title
JP2010532657A5 (OSRAM)
JP2011004753A5 (OSRAM)
JP2008525033A5 (OSRAM)
JP2008538183A5 (OSRAM)
JP2020031658A5 (OSRAM)
JP2002531522A5 (OSRAM)
JPH09322781A5 (OSRAM)
JP2002537791A5 (OSRAM)
JP2003527079A5 (OSRAM)
JP2018537087A5 (OSRAM)
JP2004511201A5 (OSRAM)
JP2002542827A5 (OSRAM)
Viseshakul et al. Sequence and expression analysis of a surface antigen gene family of the rickettsia Anaplasma marginale
JP2018537089A5 (OSRAM)
CN104844712A (zh) 肺炎链球菌蛋白抗原及其制备方法和应用
King et al. Achieving cross-reactivity with pan-ebolavirus antibodies
US9267947B2 (en) Compositions and methods for preventing or treating Burkholderia infection
CN102178950A (zh) 一种亚单位疫苗免疫佐剂及应用
JP2004535161A5 (OSRAM)
US7618635B2 (en) Super-antigen fusion proteins and the use thereof
JP2008517918A5 (OSRAM)
JP4005633B2 (ja) Ｆ型ボツリヌス毒素およびその用途
KR101635673B1 (ko) Ａ형 간염 바이러스 백신 소재 단백질 ｖｐ1-3ｎ 및 백신 조성물
CA2365196A1 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
JP2003507029A5 (OSRAM)